Yi Lao1, Minsong Cao1, Yingli Yang1, Amar U Kishan1, Wensha Yang2, Yalin Wang3, Ke Sheng1. 1. Department of Radiation Oncology, University of California, Los Angeles, California, USA. 2. Department of Radiation Oncology, University of Southern California, Los Angeles, California, USA. 3. School of Computing, Informatics, and Decision Systems Engineering, Arizona State University, Tempe, Arizona, USA.
Abstract
PURPOSE: To introduce a novel surface-based dose mapping method to improve quantitative bladder dosimetric assessment in prostate cancer (PC) radiotherapy. METHODS: Based on the planning and daily pre and postfraction MRIs of 12 PC patients, bladder surface models (SMs) were generated on manually delineated contours and regionally aligned via surface-based registration. Subsequently, bladder surface dose models (SDMs) were created using face-wise dose sampling. To determine the bladder intrafractional and interfractional motion and dose variation, we performed a pose analysis between pre and postfraction bladder SMs, as well as surface mapping for fractional SMs. Discrepancies between the received dose, accumulated from daily SDMs, and the planned dose were then assessed on the corresponding SDMs. Complementary to the surface dose mapping, dose surface histogram (DSH)-based comparisons were also performed. RESULTS: The intrafraction pose analysis revealed a significant (p < 0.05) bladder expansion, as well as an anterior/superior drift during the treatment. The intrafraction motion substantially altered dose to mid-bladder body, but not the bladder surface areas distal to or contiguous with the target. A similar pattern of dose variations was also detected by interfraction comparisons. With surface registration to the common SM, the cumulative bladder dose significantly differs from the planned dose. The discrepancy is evident in the mid-posterior range that corresponds to a mid- to high-dose region. The received DSH significantly differs from the planned DSH after permutation correction (p = 0.0122), while the overall surface-based comparison after multiple comparison correction is nonsignificant (p = 0.0800). CONCLUSIONS: We developed a novel surface-based intra and interdose mapping framework applied to a unique daily MR dataset for image-guided radiotherapy. The framework identified significant intrafraction bladder positional changes, localized the intra and interfraction variations, and quantified planned versus received dose differences on the bladder surface. The result indicates the importance of adopting the motion-integrated bladder SDM for bladder dose management.
PURPOSE: To introduce a novel surface-based dose mapping method to improve quantitative bladder dosimetric assessment in prostate cancer (PC) radiotherapy. METHODS: Based on the planning and daily pre and postfraction MRIs of 12 PC patients, bladder surface models (SMs) were generated on manually delineated contours and regionally aligned via surface-based registration. Subsequently, bladder surface dose models (SDMs) were created using face-wise dose sampling. To determine the bladder intrafractional and interfractional motion and dose variation, we performed a pose analysis between pre and postfraction bladder SMs, as well as surface mapping for fractional SMs. Discrepancies between the received dose, accumulated from daily SDMs, and the planned dose were then assessed on the corresponding SDMs. Complementary to the surface dose mapping, dose surface histogram (DSH)-based comparisons were also performed. RESULTS: The intrafraction pose analysis revealed a significant (p < 0.05) bladder expansion, as well as an anterior/superior drift during the treatment. The intrafraction motion substantially altered dose to mid-bladder body, but not the bladder surface areas distal to or contiguous with the target. A similar pattern of dose variations was also detected by interfraction comparisons. With surface registration to the common SM, the cumulative bladder dose significantly differs from the planned dose. The discrepancy is evident in the mid-posterior range that corresponds to a mid- to high-dose region. The received DSH significantly differs from the planned DSH after permutation correction (p = 0.0122), while the overall surface-based comparison after multiple comparison correction is nonsignificant (p = 0.0800). CONCLUSIONS: We developed a novel surface-based intra and interdose mapping framework applied to a unique daily MR dataset for image-guided radiotherapy. The framework identified significant intrafraction bladder positional changes, localized the intra and interfraction variations, and quantified planned versus received dose differences on the bladder surface. The result indicates the importance of adopting the motion-integrated bladder SDM for bladder dose management.
Authors: Yalin Wang; Lok Ming Lui; Xianfeng Gu; Kiralee M Hayashi; Tony F Chan; Arthur W Toga; Paul M Thompson; Shing-Tung Yau Journal: IEEE Trans Med Imaging Date: 2007-06 Impact factor: 10.048
Authors: Robert M Meier; Daniel A Bloch; Cristian Cotrutz; Alan C Beckman; George T Henning; Shermian A Woodhouse; Shirnett K Williamson; Najeeb Mohideen; John J Dombrowski; Robert L Hong; David G Brachman; Patrick W Linson; Irving D Kaplan Journal: Int J Radiat Oncol Biol Phys Date: 2018-06-01 Impact factor: 7.038
Authors: Karen Lim; James Stewart; Valerie Kelly; Jason Xie; Kristy K Brock; Joanne Moseley; Young-Bin Cho; Anthony Fyles; Anna Lundin; Henrik Rehbinder; Johan Löf; David A Jaffray; Michael Milosevic Journal: Int J Radiat Oncol Biol Phys Date: 2014-07-08 Impact factor: 7.038
Authors: Yalin Wang; Yang Song; Priya Rajagopalan; Tuo An; Krystal Liu; Yi-Yu Chou; Boris Gutman; Arthur W Toga; Paul M Thompson Journal: Neuroimage Date: 2011-03-23 Impact factor: 6.556